High materiality7/10
Hemab Therapeutics initiated with a Buy at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Hemab Therapeutics (COAG) received a Buy initiation from H.C. Wainwright with a $40 target. Current price: $25.51. Price Change Since Signal: +3.68.
- H.C. Wainwright initiates Buy; target $40; price $25.51; +3.68
Key facts
- 01
Target: $40
- 02
Posted price: $25.51
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.